Latanoprost

Stop Retinal Ganglion Cell Dysfunction Study

A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China

Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser

Comparison of Latanoprost Vs. Timolol

Circadian Rhythms of Aqueous Humor Dynamics in Humans

Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation

A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329

Prospective, Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Glaucoma and Ocular Hypertension Patients With Corneal Disorders (Switching From 0.005% Latanoprost Ophthalmic Solution)

A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.

A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma

A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.

Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension

CATS Tonometer IOP Reduction Latanoprost Verses Timolol

A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients

Blood Flow of Ophthalmic Artery and Glaucoma

Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma

A Clinical Study to Evaluate the Efficacy and Safety of CKD-351

Microneedling and Latanoprost in Acrofacial Vitiligo

Eyenovia MiDD Usability Study

Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular Hypertension